Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Luis Ruilope"'
Autor:
Michel Burnier, Shanyan Lin, Luis Ruilope, Giovanni Bader, Sharanbasappa Durg, Patrick Brunel
Publikováno v:
Blood Pressure, Vol 28, Iss 6, Pp 358-374 (2019)
Objective: Angiotensin receptor blockers (ARB) are among the recommended first-line treatment options in patients with hypertension and chronic kidney disease (CKD). This meta-analysis evaluated the effect of ARB on blood pressure (BP) and renal func
Externí odkaz:
https://doaj.org/article/37f228db1ba94e519144d17d240450ac
Autor:
Bryan Williams, Giuseppe Mancia, Wilko Spiering, Enrico Agabiti Rosei, Michel Azizi, Michel Burnier, Denis Clement, Antonio Coca, Giovanni De Simone, Anna Dominiczak, Thomas Kahan, Felix Mahfoud, Josep Redon, Luis Ruilope, Alberto Zanchetti, Mary Kerins, Sverre Kjeldsen, Reinhold Kreutz, Stéphane Laurent, Gregory Y. H. Lip, Richard McManus, Krzysztof Narkiewicz, Frank Ruschitzka, Roland Schmieder, Evgeny Shlyakhto, Konstantinos Tsioufis, Victor Aboyans, Ileana Desormais
Publikováno v:
Blood Pressure, Vol 27, Iss 6, Pp 314-340 (2018)
These practice guidelines on the management of arterial hypertension are a concise summary of the more extensive ones prepared by the Task Force jointly appointed by the European Society of Hypertension and the European Society of Cardiology. These g
Externí odkaz:
https://doaj.org/article/3c59bfd8b10d450694712d82fbcd5e60
Publikováno v:
F1000Research, Vol 8 (2019)
Since the association of microalbuminuria (MAU) with cardiovascular (CV) risk was described, a huge number of reports have emerged. MAU is a specific integrated marker of CV risk and targets organ damage in patients with hypertension, chronic kidney
Externí odkaz:
https://doaj.org/article/ccdd8d9740ab4ba38cf378174d76087d
Publikováno v:
F1000Research, Vol 6 (2017)
Arterial hypertension and chronic kidney disease (CKD) are intimately related. The control of blood pressure (BP) levels is strongly recommended in patients with CKD in order to protect the kidney against the accompanying elevation in global cardiova
Externí odkaz:
https://doaj.org/article/e464488d959e4325895dbc45afbb4aa3
Autor:
Felix Mahfoud, Giuseppe Mancia, Roland E. Schmieder, Luis Ruilope, Krzysztof Narkiewicz, Markus Schlaich, Bryan Williams, Flavio Ribichini, Joachim Weil, Hsien-Li Kao, Oriol Rodriguez-Leor, Elias Noory, Tiong Kiam Ong, Thierry Unterseeh, Pedro de Araújo Gonçalves, Andreas Zirlik, Khaled Almerri, Faisal Sharif, Lucas Lauder, Marianne Wanten, Martin Fahy, Michael Böhm
Publikováno v:
Journal of the American College of Cardiology. 80(20)
Renal denervation (RDN) has been shown to lower blood pressure (BP), but its effects on cardiovascular events have only been preliminarily evaluated. Time in therapeutic range (TTR) of BP is associated with cardiovascular events.This study sought to
Autor:
Tzung-Dau Wang, Markus Schlaich, Felix Mahfoud, Bryan Wiliams, Luis Ruilope, Krzystzof Narkiewicz, Martin Fahy, Giuseppe Mancia, Michael Böhm
Publikováno v:
Journal of the American College of Cardiology. 81:S2
Autor:
Pantelis Sarafidis, Luis Ruilope, Stefan D Anker, Rajiv Agarwal, Bertram Pitt, Gerasimos Filippatos, Peter Rossing, Katherine Tuttle, Ioannis Boletis, Robert Toto, Christoph Wanner, Liu Zhi-Hong, Christiane Ahlers, Meike Brinker, Robert Lawatscheck, Amer Joseph, George Bakris
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Patients with stage 4 chronic kidney disease (CKD) and type 2 diabetes (T2D) have a high residual risk of cardiovascular (CV) and kidney disease progression, and effective treatment options to reduce the risk are limited. The non-
Autor:
Markus Schlaich, Jan Benjamin Pietzsch, Felix Mahfoud, Bryan Wiliams, Giuseppe Mancia, Krzystzof Narkiewicz, Luis Ruilope, Doug Hettrick, Michael Böhm, Roland E. Schmieder
Publikováno v:
Journal of the American College of Cardiology. 79:S30-S31
Autor:
Alejandro de la Sierra, Luis Ruilope, Pablo Martinez-Camblor, Ernest Vinyoles, Manuel Gorostidi, Julian Segura, Bryan Williams
Publikováno v:
Journal of Hypertension. 40:e60
Autor:
Felix Mahfoud, Roland Schmieder, Markus Schlaich, Krzysztof Narkiewicz, Luis Ruilope, Bryan Williams, Martin Fahy, Giuseppe Mancia, Michael Bohm
Publikováno v:
Journal of Hypertension. 40:e290